Clinical Trials Logo

Clinical Trial Summary

Our study intends to demonstrate that the selection of an embryo to transfer it at the sage of blastocyst through morphokinetics (analysis of embryos depending not only in their morphology —that is, the aspect of the embryo—, but also based on times of cell division) during the use of time-lapse (Embryoscope®) may have a better impact in clinical results, as selection is not performed in mere morphological evolution (visual aspect of the embryo) of the embryos.


Clinical Trial Description

Our study intends to demonstrate that the selection of an embryo to transfer it at the sage of blastocyst through morphokinetics (analysis of embryos depending not only in their morphology —that is, the aspect of the embryo—, but also based on times of cell division) during the use of time-lapse (Embryoscope®) may have a better impact in clinical results, as selection is not performed in mere morphological evolution (visual aspect of the embryo) of the embryos.

In order to obtain this objective, patients participating in the study will be randomly assigned to one of the following groups:

Group A: Patients who will perform an embryo transfer of a blastocyst using morphological criteria to evaluate que quality of the blastocyst (Gardner Classification), that is, based on the aspect or form of the embryo.

Group B: Patients who will perform an embryo transfer of a blastocyst using morphokinetics criteria to evaluate the quality of the blastocyst (Embryoscope®), that is, based not only in the aspect of the embryo but also in cell division times experimented by the embryos. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04003337
Study type Interventional
Source Procreatec
Contact Ester Padilla
Phone 0034914585804
Email esterpadilla@procreatec.com
Status Recruiting
Phase N/A
Start date January 26, 2017
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT02032797 - Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone. Phase 4
Completed NCT04077970 - Intrauterine Flushing With Follicular Fluid Plus Granulosa Cells Phase 3
Terminated NCT00588250 - Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates N/A
Completed NCT03485235 - Effect of Dilatation and Curettage on the Endometrial Receptivity N/A
Recruiting NCT02072291 - Nifedipine Treatment on Uterine Contractility in IVF Phase 2
Completed NCT02815371 - Laser Acupuncture Before and After Embryo Transfer Improves IVF Outcomes N/A
Completed NCT04855383 - Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles N/A
Recruiting NCT04721522 - The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome
Completed NCT02407730 - EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies
Completed NCT00635258 - Administration of GnRH Antagonist to Oocyte Donation Recipients N/A
Completed NCT03108157 - Endometrial Scratch Effect on Pregnancy Rates in Patients Undergoing Egg-donation IVF N/A
Terminated NCT04744844 - DNA Amplification in Blastocoel Fluid N/A
Active, not recruiting NCT05555121 - Rescue Progesterone Supplementation During Frozen Embryo Transfer Phase 2
Recruiting NCT04159649 - The Outcomes of ICSI Cycles With and Without Letrozole Phase 4
Not yet recruiting NCT00506480 - Assessment of Endometrial Receptivity in Recipients of Donated Oocytes N/A
Completed NCT03128970 - Synchronizing Blastocyst in Frozen Embryo Transfer N/A